Chief Scientist of SFDA Jop-hopped to Pharmaceutical Company
Update time：2018-05-20 17:13:00 Views：
It is said that chief scientist of the Center for Drug Evaluation of the SFDA, Wang Gang served as vice president of WuXi PharmaTech, and was expected to earn over 5 million yuan annually.
Recently, Wang Gang, former chief scientist of the Center for Drug Evaluation of the SFDA, attended the meeting as Vice President of WuXi PharmaTech.
▍Dr. Gang Wang, a recognized expert at home and abroad
According to public information, Dr. Gang Wang once was the chief scientist of the Center for Drug Evaluation of the SFDA. He is mainly responsible for establishing, implementing, and improving the compliance and inspection work related to CDE drug review.
Prior to joining CDE, Dr. Wang Gang worked in the FDA for nearly 12 years and has extensive practical experience in biological product review and international GMP compliance inspections. He is a recognized expert in the field of biopharmaceutical review and inspection at home and abroad.
Now several Chiefs of CDE: Chief Scientist: He Ruyi, Chief Scientist of Toxicology Pharmacology: Xu Zengjun, Chief Scientist of Reviewing Business : Qian Jiahua, Chief Reviewer: Wang Tao.
Regarding the departure of Dr. Wang Gang, some insiders commented that the flow of personnel is a normal phenomenon, and the top-level system design of of the Center for Drug Evaluation of the SFDA is even more critical.
▍Well-paid executives in WuXi PharmaTech
In the capital market, WuXi PharmaTech is undoubtedly a dazzling star. Matching capital market stars is the personal income of WuXi PharmaTech from the chairman to the employees.
The prospectus shows that, from 2015 to 2017, the main business income of WuXi PharmaTech was 4.875 billion yuan, 6.048 billion yuan and 7.72 billion yuan, respectively, and the compound annual growth rate of 2015-2017 was 25.85%, and the yield was good.
According to public information, Li Ge, chairman of WuXi PharmaTech, has a annual salary of over 10 million. At the same time, in several companies with a market capitalization of over one hundred billion yuan, only the chairman of Fosun Pharm has reached this level.
The annual salary of the chairman of Hengrui Medicine is only RMB 1.7 million, the annual salary of chairman of Kangmei Pharmaceutical is RMB 709,300, and the annual salary of Chairman of Yunnan Baiyao is only RMB 18,600.
According to other data, the total amount of cash paid for employees by 25 listed companies in the pharmaceutical industry, such as WuXi PharmaTech and Shanghai Pharmaceuticals, Baiyunshan, Fosun Pharma, Tong Ren Tang, Kyushu Tong, Midea Health, China Resources Sanjiu, Harbin Pharmaceutical Co., Ltd., Sinopharm Co., Ltd., Tasly, Aier Eye, Andisu, Yunnan Baiyao exceeded RMB 1 billion.
As a result, industry insiders speculated that Dr. Wang Gang’s annual salary after going to business is expected to exceed 5 million.